We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BRPT:IDXPT Barito Pacific Tbk Analysis

Data as of 2026-05-29 - not real-time

IDR 1,940.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

PT Barito Pacific Tbk (BRPT) shows a mixed technical picture: momentum indicators sit in a neutral range while the MACD has turned bearish, suggesting short‑term downside pressure. The stock trades well below its 200‑day moving average, indicating a potential valuation gap relative to its long‑term trend. On the fundamentals side, the price‑earnings multiple sits in the high‑teens, debt levels are high with a debt‑to‑equity ratio above 130%, but return on equity remains strong and cash generation is positive, albeit offset by negative free cash flow. The market sentiment is extremely bullish as reflected by the fear‑greed index, yet volatility is elevated, and trading volume remains stable.
Given the undervalued pricing relative to long‑term averages and the solid profitability metrics, the stock presents a value‑oriented opportunity for investors with a longer horizon, while short‑term traders should remain cautious due to bearish momentum signals and high price swings.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD histogram indicates downward pressure
  • High 30‑day price volatility
  • Price still above immediate support but below long‑term resistance

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Stock priced below 200‑day SMA suggesting upside potential
  • Strong ROE and operating margins despite high leverage
  • Stable trading volume reducing execution risk

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Diversified business lines (petrochemicals, energy, property) provide resilience
  • Value‑oriented valuation with PE in moderate range
  • Low beta indicating limited sensitivity to broader market swings

Key Metrics & Analysis

Financial Health

Revenue Growth232.20%
Profit Margin5.98%
P/E Ratio18.0
ROE34.82%
ROA0.98%
Debt/Equity133.91
P/B Ratio77600.0
Op. Cash FlowIDR413.9M
Free Cash FlowIDR-1247792384

Technical Analysis

TrendNeutral
RSI53.0
SupportIDR 1,460.00
ResistanceIDR 2,450.00
MA 20IDR 1,903.75
MA 50IDR 1,830.50
MA 200IDR 2,657.43
MACDBearish
VolumeStable
Fear & Greed Index94.07

Valuation

Fair ValueIDR 0.06
Target PriceIDR 2,548.17
Upside/Downside31.35%
GradeUndervalued
TypeValue

Risk Assessment

Beta0.39
Volatility129.83%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.